Based on our findings in mice we conclude, that the expression of KLF4 in monocytes/macrophages and PMNs promotes the early pro-inflammatory immune response and, thereby, pneumococcal elimination in patients with pneumococcal pneumonia, which might result in reduced disease severity upon presentation to hospital and eventually a favourable further hospital course. Here, KLF4 is linked to pneumococcal pneumonia.